Searching map area
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial
? TBD
scientific article
Nobody has rated this yet. Be the first!
Lists 0